Marc L. Steuer
2009
In 2009, Marc L. Steuer earned a total compensation of $439.9K as Senior Vice President, Business Development at MabVax Therapeutics Holdings, a 30% increase compared to previous year.
Compensation breakdown
| Option Awards | $139,908 |
|---|---|
| Salary | $300,000 |
| Total | $439,908 |
Steuer received $300K in salary, accounting for 68% of the total pay in 2009.
Steuer also received $139.9K in option awards.
Rankings
In 2009, Marc L. Steuer's compensation ranked 7,281st out of 9,885 executives tracked by ExecPay. In other words, Steuer earned more than 26.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,281 out of 9,885 | 26th |
Division Manufacturing | 2,700 out of 3,690 | 27th |
Major group Chemicals And Allied Products | 611 out of 871 | 30th |
Industry group Drugs | 429 out of 643 | 33rd |
Industry Pharmaceutical Preparations | 312 out of 446 | 30th |
Source: SEC filing on April 7, 2010.
Steuer's colleagues
We found four more compensation records of executives who worked with Marc L. Steuer at MabVax Therapeutics Holdings in 2009.
2009
Michael Wick
MabVax Therapeutics Holdings
Chief Executive Officer
2009
Cynthia Butitta
MabVax Therapeutics Holdings
Chief Financial Officer
2009
William Kaplan
MabVax Therapeutics Holdings
General Counsel
2009
Stefan Ryser
MabVax Therapeutics Holdings